Strategic Minerals Plc Stock Price Today (NSE: SML)
Fundamental Score
Strategic Minerals Plc Share Price — Live NSE/BSE Price, Fundamentals & Analysis
Strategic Minerals Plc share price today is ₹73.00, up +0.00% on NSE/BSE as of 2 June 2026. Strategic Minerals Plc (SML) is a Small-cap company in the Hospital sector with a market capitalisation of ₹42.95 (Cr). The 52-week high for SML share price is ₹114.15 and the 52-week low is ₹43.82. The company has a Return on Equity (ROE) of -13.10% and a debt-to-equity ratio of 123.33.
Strategic Minerals Plc Share Price Chart — NSE/BSE Historical Performance
Strategic Minerals Plc share price chart: 3.96% return over the past month. 52-week high ₹114.15, 52-week low ₹43.82.
Strategic Minerals Plc — Last 10 Trading Days
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) | |
| ₹73.00 | ₹73.00 | ₹73.00 | ₹73.00 | 0.00 (Cr) |
Strategic Minerals Plc — Last 12 Months Price History
| Month | Open | High | Low | Close | Change |
|---|---|---|---|---|---|
| ₹70.22 | ₹73.70 | ₹66.71 | ₹73.00 | +3.96% | |
| ₹70.22 | ₹70.22 | ₹70.22 | ₹70.22 | +0.00% | |
| ₹48.54 | ₹70.22 | ₹43.82 | ₹70.22 | +44.66% | |
| ₹100.70 | ₹100.70 | ₹51.09 | ₹51.09 | -49.27% | |
| ₹100.70 | ₹100.70 | ₹95.70 | ₹100.70 | +0.00% | |
| ₹100.70 | ₹100.70 | ₹100.70 | ₹100.70 | +0.00% | |
| ₹108.50 | ₹109.70 | ₹93.40 | ₹100.70 | -7.19% | |
| ₹103.40 | ₹114.15 | ₹95.70 | ₹109.00 | +5.42% | |
| ₹86.72 | ₹109.93 | ₹86.72 | ₹103.40 | +19.23% | |
| ₹57.71 | ₹85.02 | ₹54.75 | ₹85.02 | +47.32% | |
| ₹45.80 | ₹59.20 | ₹45.80 | ₹58.00 | +26.64% | |
| ₹58.47 | ₹58.47 | ₹45.75 | ₹48.15 | -17.65% |
Returns & Performance
Return on Equity (ROE)
Profit generated per ₹1 of shareholder equity
Return on Capital (ROCE)
Returns generated on total capital deployed
Oper. Profit Margin (5Y Avg)
Average operating profit margin over 5 years
Dividend Yield
Annual dividend as % of current share price
Strategic Minerals Plc Valuation Check
Price to Earnings (P/E)
Share price ÷ earnings per share. Lower = cheaper
Industry Avg P/E
Average P/E of all peers in this sector
Market Capitalisation
Total market value of all outstanding shares
Growth Engine
Profit Growth (Quarterly YoY)
Net profit growth vs same quarter last year
Revenue Growth (Quarterly YoY)
Revenue growth vs same quarter last year
Revenue Growth (5-Year CAGR)
Compounded annual revenue growth over 5 years
EPS Growth (5-Year CAGR)
Earnings per share growth over 5 years
Net Profit Growth (5-Year CAGR)
Compounded annual net profit growth over 5 years
Balance Sheet Health
Debt to Equity Ratio
Total debt ÷ equity. Below 0.5 = financially healthy
Interest Coverage Ratio
EBIT ÷ interest expense. Above 2.5 = can pay interest comfortably
Free Cash Flow (5-Year Total)
Cash left after capex over 5 years. Positive = self-funded growth
Labels (e.g., "Excellent", "Good") are peer-based vs industry/sector averages — data-only, not advice
Strategic Minerals Plc Fundamental Analysis & Valuation Benchmarking
Educational evaluation of SML across key market metrics for learning purposes.
Positive Indicators
3 factors identified
Consistent Growth Track Record (15.87% CAGR)
Observation: Strong 5-year sales compound annual growth rate.
Analysis: Consistent sales CAGR >12% demonstrates sustainable growth model.
Balanced Promoter Holding (69.79%)
Observation: Optimal balance between promoter control and public float.
Analysis: Promoter holding in 50-75% range provides management alignment.
Zero Share Pledging Risk
Observation: No promoter shares pledged as collateral.
Analysis: Absence of share pledging eliminates potential forced-selling pressure.
Risk Factors
8 factors identified
Below-Average Return on Equity (-13.10%)
Observation: Returns on equity are below industry benchmarks.
Analysis: ROE <10% may indicate inefficient capital utilization. Consider monitoring for operational improvements and management effectiveness.
Suboptimal ROCE (6.64%)
Observation: Returns on capital employed are below expectations.
Analysis: ROCE <10% suggests potential inefficiencies in capital allocation.
Margin Pressure Concerns (-0.83%)
Observation: Operating margins are below industry standards.
Analysis: OPM <5% may indicate pricing pressures or cost management challenges.
Profit Decline Concern (-295.74%)
Observation: Significant year-over-year profit contraction observed.
Analysis: Declining profitability requires investigation into underlying causes.
Revenue Contraction (-24.21%)
Observation: Sales decline may indicate market challenges or competitive pressures.
Analysis: Negative revenue growth requires analysis of market conditions.
Elevated Debt Levels (D/E: 123.33)
Observation: High leverage increases financial risk and interest burden.
Analysis: High debt-to-equity ratios require monitoring of debt servicing capability.
Weak Interest Coverage (0.01x)
Observation: Limited ability to service debt obligations from earnings.
Analysis: Low interest coverage raises concerns about financial stability.
No Dividend Distribution
Observation: Company does not currently pay dividends to shareholders.
Analysis: Zero dividend yield may indicate growth reinvestment focus or cash flow constraints.
Strategic Minerals Plc vs Hospital Peers
Peer Comparison - Hospital
Compare Strategic Minerals Plc with 10 other companies in the same sector
| Company Info | Fundamental | Valuation | Profitability | Financial Health | Growth | Dividend | ||||
|---|---|---|---|---|---|---|---|---|---|---|
Company Company name | Score Bull Run comprehensive fundamental score based on 20+ metrics | Price Current trading price of the stock | Market Cap Total value of all shares in the market | P/E Price per share divided by earnings per share | ROE Net income divided by shareholder equity | ROCE Earnings before interest and tax divided by capital employed | Debt/Eq Total debt divided by total equity | Profit 5Y Average annual profit growth over 5 years | Sales 5Y Average annual sales growth over 5 years | Dividend Annual dividend per share divided by price per share |
18.2/100 | ₹73.00₹73 | ₹42.95₹42.95 | — — | -13.10%Poor -13.10% Poor | 6.64%Poor 6.64% Poor | 123.33Poor 123.3 Poor | 13.10%Good 13.10% Good | 15.87%Excellent 15.87% Excellent | 0.00% | |
Max Healthcare Institute LtdMax Healthcare ... MAXHEALTH • 543220 | 69.1/100 | ₹993.45₹993 | ₹109416.28₹109416.28 | 77.65Average 77.7 Average | 12.72%Average 12.72% Average | 14.88%Average 14.88% Average | 0.33Excellent 0.3 Excellent | 80.50%Excellent 80.50% Excellent | 46.01%Excellent 46.01% Excellent | 0.13% |
Apollo Hospitals Enterprise LtdApollo Hospital... APOLLOHOSP • 508869 | 50.2/100 | ₹8272.50₹8273 | ₹104825.94₹104825.94 | 62.70Average 62.7 Average | 18.42%Good 18.42% Good | 16.64%Good 16.64% Good | 0.88Good 0.9 Good | 33.72%Excellent 33.72% Excellent | 14.15%Good 14.15% Good | 0.26% |
Fortis Healthcare LtdFortis Healthca... FORTIS • 532843 | 55.6/100 | ₹960.90₹961 | ₹68301.24₹68301.24 | 67.80Average 67.8 Average | 10.13%Average 10.13% Average | 11.96%Average 11.96% Average | 0.34Excellent 0.3 Excellent | 70.31%Excellent 70.31% Excellent | 10.93%Good 10.93% Good | 0.11% |
Narayana Hrudayalaya LtdNarayana Hruday... NH • 539551 | 62.2/100 | ₹1920.20₹1920 | ₹39051.19₹39051.19 | 45.92Average 45.9 Average | 24.22%Excellent 24.22% Excellent | 20.75%Excellent 20.75% Excellent | 0.58Good 0.6 Good | 43.49%Excellent 43.49% Excellent | 11.88%Good 11.88% Good | 0.24% |
Aster DM Healthcare LtdAster DM Health... ASTERDM • 540975 | 15.4/100 | ₹741.25₹741 | ₹34688.15₹34688.15 | 94.51Average 94.5 Average | 8.26%Poor 8.26% Poor | 10.68%Average 10.68% Average | 0.46Excellent 0.5 Excellent | -7.24%Poor -7.24% Poor | -13.71%Poor -13.71% Poor | 0.75% |
Global Health LtdGlobal Health L... MEDANTA • 543654 | 61/100 | ₹1207.80₹1208 | ₹33498.00₹33498.00 | 56.03Average 56.0 Average | 16.48%Good 16.48% Good | 19.74%Good 19.74% Good | 0.25Excellent 0.3 Excellent | 70.15%Excellent 70.15% Excellent | 19.73%Excellent 19.73% Excellent | 0.04% |
45.1/100 | ₹784.45₹784 | ₹27605.54₹27605.54 | 83.99Average 84.0 Average | 18.48%Good 18.48% Good | 15.00%Good 15.00% Good | 1.40Average 1.4 Average | 25.01%Excellent 25.01% Excellent | 22.01%Excellent 22.01% Excellent | 0.00% | |
Dr Agarwals Health Care LtdDr Agarwals Hea... AGARWALEYE • 544350 | 51.2/100 | ₹479.95₹480 | ₹16844.04₹16844.04 | 145.15Average 145.2 Average | 4.76%Poor 4.76% Poor | 9.99%Poor 9.99% Poor | 0.51Good 0.5 Good | 41.72%Excellent 41.72% Excellent | 26.38%Excellent 26.38% Excellent | 0.00% |
Rainbow Childrens Medicare Pvt LtdRainbow Childre... RAINBOW • 543524 | 54.6/100 | ₹1377.10₹1377 | ₹13410.38₹13410.38 | 52.84Average 52.8 Average | 17.43%Good 17.43% Good | 18.69%Good 18.69% Good | 0.54Good 0.5 Good | 33.66%Excellent 33.66% Excellent | 16.08%Excellent 16.08% Excellent | 0.23% |
36.4/100 | ₹659.95₹660 | ₹10474.40₹10474.40 | 296.22Average 296.2 Average | 5.14%Poor 5.14% Poor | 8.56%Poor 8.56% Poor | 1.92Average 1.9 Average | 19.34%Excellent 19.34% Excellent | 15.22%Excellent 15.22% Excellent | 0.00% | |
Top Hospital Stocks
View all →By Bull Run Score
By Return on Equity
By Market Cap
- Max Healthcare Institute Ltd share price109416.28 Cr
- Apollo Hospitals Enterprise Ltd share price104825.94 Cr
- Fortis Healthcare Ltd share price68301.24 Cr
- Narayana Hrudayalaya Ltd share price39051.19 Cr
- Aster DM Healthcare Ltd share price34688.15 Cr
Strategic Minerals Plc Quarterly Performance
Latest quarterly metrics for SML — revenue growth and profit growth vs same quarter last year
Revenue Growth (YoY)
-24.21%
Latest quarter vs same quarter previous year
Net Profit Growth (YoY)
-295.74%
Latest quarter net profit vs same quarter previous year
5-Year Revenue CAGR
15.87%
Compounded annual revenue growth over 5 years
5-Year Profit CAGR
13.10%
Compounded annual net profit growth over 5 years
Strategic Minerals Plc Technical Indicators
SMA 50, SMA 200, RSI and volume signals for SML — calculated from daily price history
Momentum is strong — price may be stretched. Watch for pullbacks.
Technical indicators are for educational purposes only. Not investment advice.
Strategic Minerals Plc Financial Statements
Annual income statement, balance sheet and cash flow for Strategic Minerals Plc (SML) — sourced from NSE/BSE filings.
Loading Financial Statements...
Fetching financial data for Strategic Minerals Plc
About SML (Strategic Minerals Plc)
Strategic Minerals Plc is undergoing a thorough diagnostic evaluation within the sterile confines of St. Jude's Hospital. Having presented with an acute case of unforeseen financia...l instability, SML is currently hooked up to various monitoring devices tracking key performance indicators like share price fluctuations, debt levels, and investor sentiment. A dedicated team of specialists, including financial analysts acting as attending physicians and corporate restructuring experts serving as surgeons, are meticulously scrutinizing the company's balance sheets, cash flow statements, and operational reports. The air hangs heavy with anticipation as these specialists attempt to determine the root cause of the company's sudden downturn, with potential diagnoses ranging from market volatility and supply chain disruptions to internal mismanagement and aggressive competitor activity. The current course of treatment involves a battery of tests designed to identify any underlying structural weaknesses. SML is undergoing intensive stress tests, simulating various economic downturn scenarios, to assess its resilience. Scans are being performed on its asset portfolio to determine the true value of its holdings and identify any potential impairments. A rigorous review of its strategic partnerships and supply contracts is underway, seeking to uncover any potential liabilities or vulnerabilities. The results of these investigations will be crucial in determining the prognosis for SML's long-term health, and will inform the development of a comprehensive recovery plan aimed at restoring the company to a state of financial stability and robust growth. The atmosphere surrounding SML is one of cautious optimism mingled with palpable concern. While the situation is undeniably serious, the medical team – comprised of consultants and stakeholders – remains confident in its ability to identify the core issues and implement effective solutions. Regular updates are being provided to investors and concerned parties, albeit cautiously worded to avoid exacerbating market anxieties. The long-term goal is a full recovery, enabling SML to return to the marketplace as a stronger, more resilient entity, equipped to navigate the ever-changing landscape of the global resource sector. The recovery process will be lengthy and demanding, requiring unwavering commitment from all involved, but the belief in SML's underlying potential remains steadfast.
Company Details
Key Leadership
Latest News
SML Share Price: Frequently Asked Questions
What is the current share price of Strategic Minerals Plc?
Strategic Minerals Plc (SML) trades at ₹73.00 on NSE and BSE. Market cap ₹42.95 (Cr). Educational data only.
What is the P/E ratio of Strategic Minerals Plc?
Strategic Minerals Plc has a P/E of N/Ax vs industry average 52.84x.
What is the Bull Run score for Strategic Minerals Plc?
Strategic Minerals Plc has a Bull Run score of 18.2/100 based on 25+ financial parameters.
Does Strategic Minerals Plc pay dividends?
Strategic Minerals Plc has a dividend yield of 0.00%. Past dividends don't guarantee future payments.
What is the ROE of Strategic Minerals Plc?
Strategic Minerals Plc has ROE of -13.10%. Higher ROE indicates better use of shareholder equity.
What is the debt-to-equity ratio of Strategic Minerals Plc?
Strategic Minerals Plc has debt-to-equity of 123.33.
Is Strategic Minerals Plc a good investment?
Bull Run gives Strategic Minerals Plc a score of 18.2/100. This is not investment advice — consult a SEBI-registered advisor.